Progesterone formulations

  • US 10,639,375 B2
  • Filed: 07/17/2018
  • Issued: 05/05/2020
  • Est. Priority Date: 06/18/2012
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical composition comprising:

  • progesterone and an effective amount of estradiol not exceeding 2 mg, wherein the estradiol and progesterone are present in a weight ratio of 1;

    100;

    a medium chain oil; and

    a non-ionic surfactant;

    further wherein the progesterone is present from about 20 to about 50 weight percent of the composition.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×